Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,242.27 -753.64 (-1.18%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
Wilmar International Limited (F34.SI)
SES - SES Delayed price. Currency in SGD
Add to watchlist
At close: 05:07PM SGT
| Previous close | 3.5000 |
| Open | 3.4700 |
| Bid | 3.4600 x 0 |
| Ask | 3.4700 x 0 |
| Day's range | 3.4500 - 3.5000 |
| 52-week range | 3.0700 - 4.1000 |
| Volume | |
| Avg. volume | 5,202,313 |
| Market cap | 21.662B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 10.52 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.17 (4.90%) |
| Ex-dividend date | 29 Apr 2024 |
| 1y target est | N/A |
- PR Newswire
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.
Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, is pleased to announce the establishment of a Memorandum of Understanding (MOU) with A*STAR's Institute of Molecular and Cell Biology (IMCB). This collaboration aims to accelerate research and treatment initiatives for neurological disorders and diseases to enhance overall health and brain function.
© 2024 Yahoo. All rights reserved.